DT
Deep Track Capital, LP cut its OBX stake below 5%
Deep Track Capital, LP reported owning 3.4% of Obsidian Therapeutics, Inc. (OBX) (2,120,050 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G